NEW

GE Healthcare Invests $50M in Wisconsin Facility

GE Healthcare has announced a $50 million investment in its existing West Milwaukee facility as part of its intention (proposal only; final decision to be made after required bargaining with relevant unions) to concentrate teams and resources in key facilities across...

New Version of c.cam Cardiac SPECT System Debuts in U.S.

Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total...

Physicians Highlight Potential of Radiopharmaceuticals in Oncology

The Medical Imaging & Technology Alliance (MITA), along with the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) and the Society of Nuclear Medicine & Molecular Imaging (SNMMI), hosted a virtual briefing for Capitol Hill staff this month with...

Nanox Signs Agreement to Deploy 630 Units in Mexico

NANO-X IMAGING LTD, an innovative medical imaging technology company, announced that it has entered into an exclusive distribution agreement with SPI Medical (SPI) for the deployment and introduction of Nanox’s medical imaging services in Mexico. SPI Medical, S. A. P....

EOS imaging Announces First Installation of EOSedge in North America

EOS imaging has announced the first installation of its new EOSedge system in North America at CHU Sainte-Justine Mother and Child University Hospital Centre in Montreal, Quebec, Canada.

This second EOSedge system installation worldwide follows the first system install in 2019 in Lyon, France. EOSedge is installed in Ste Justine hospital’s orthopedic department.

A clinical research program with EOSedge led by Professor Carl-Éric Aubin and Dr. Stefan Parent at CHU Sainte-Justine will cover a wide range of areas such as multi-spectral imaging and biomechanical modeling in multiple clinical applications, as well as clinical studies on adolescent idiopathic scoliosis and bone metabolic conditions.

Mike Lobinsky, Chief Executive Officer of EOS imaging, commented, “We are pleased that the first North American installation of our newly FDA and Health Canada cleared EOSedge system is at an institution with a dedicated value to advancing patient care. This installation marks another step in deploying, on a global scale a solution that not only further improves our dose reduction and whole-body imaging capabilities, but also adds new and unrivaled performance in image resolution and quality. We look forward to quick adoption of this outstanding imaging solution.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *